Analysts expect that IntriCon Co. (NASDAQ:IIN) will announce sales of $30.30 million for the current fiscal quarter, according to Zacks Investment Research. Two analysts have provided estimates for IntriCon’s earnings. IntriCon reported sales of $22.23 million during the same quarter last year, which indicates a positive year-over-year growth rate of 36.3%. The business is expected to report its next quarterly earnings report on Monday, February 11th.
On average, analysts expect that IntriCon will report full year sales of $115.93 million for the current financial year, with estimates ranging from $115.90 million to $115.96 million. For the next year, analysts expect that the business will report sales of $138.17 million, with estimates ranging from $136.50 million to $139.84 million. Zacks’ sales calculations are an average based on a survey of research firms that that provide coverage for IntriCon.
IntriCon (NASDAQ:IIN) last announced its quarterly earnings data on Monday, November 5th. The technology company reported $0.22 earnings per share for the quarter, topping the consensus estimate of $0.20 by $0.02. IntriCon had a return on equity of 13.06% and a net margin of 4.82%. The business had revenue of $30.13 million during the quarter, compared to the consensus estimate of $30.23 million.
IIN has been the subject of several research reports. TheStreet downgraded IntriCon from a “b” rating to a “c+” rating in a research report on Monday, October 1st. BidaskClub downgraded IntriCon from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, November 13th. ValuEngine downgraded IntriCon from a “strong-buy” rating to a “buy” rating in a research report on Friday, December 7th. Zacks Investment Research upgraded IntriCon from a “hold” rating to a “buy” rating and set a $50.00 target price for the company in a research report on Wednesday, October 24th. Finally, Stifel Nicolaus increased their target price on IntriCon from $65.00 to $70.00 and gave the company a “buy” rating in a research report on Friday, September 21st. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. IntriCon presently has an average rating of “Buy” and an average price target of $48.50.
Shares of IIN stock opened at $25.75 on Monday. IntriCon has a twelve month low of $16.70 and a twelve month high of $76.80. The firm has a market cap of $222.50 million, a P/E ratio of 88.79, a price-to-earnings-growth ratio of 2.98 and a beta of 0.95.
Institutional investors and hedge funds have recently modified their holdings of the company. First Mercantile Trust Co. acquired a new stake in IntriCon during the third quarter worth approximately $159,000. GSA Capital Partners LLP bought a new stake in IntriCon during the second quarter worth $226,000. Rhumbline Advisers bought a new stake in IntriCon during the second quarter worth $232,000. CAPROCK Group Inc. bought a new stake in IntriCon during the third quarter worth $251,000. Finally, Los Angeles Capital Management & Equity Research Inc. bought a new stake in IntriCon during the third quarter worth $270,000. Institutional investors own 59.51% of the company’s stock.
IntriCon Corporation, together with its subsidiaries, designs, develops, engineers, manufactures, and distributes body-worn devices in the United States, Europe, Asia, and internationally. The company operates in two segments, Body Worn Devices and Hearing Health Direct-To-Consumer. It offers micro-miniature products, microelectronics; micro-mechanical assemblies; high-precision injection-molded plastic components; and assemblies and software solutions for medical bio-telemetry devices, hearing healthcare, and professional audio communication devices markets.
See Also: How to read a candlestick chart
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for IntriCon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntriCon and related companies with MarketBeat.com's FREE daily email newsletter.